newsfilter
← Latest News
GlobeNewswire·

Kalaris and AlloVir Announce Stockholder Approval of Merger

PALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. ("Kalaris"), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of